Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Observation × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Plasma cell 1 Gastrointestinal 1 Dermatologic 1

Conditions

Melanoma 5 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Skin Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Peripheral Blood Stem Cell Transplantation 17 fludarabine phosphate 15 Cyclophosphamide 14 Mycophenolic Acid 13 Cyclosporine 13 Whole-Body Irradiation 12 Tacrolimus 8 Radiotherapy 8 Methotrexate 7 Melphalan 7 Busulfan 7 pembrolizumab 6 Antilymphocyte Serum 6 Nivolumab 5 Methylprednisolone 5 Filgrastim 5 Etoposide 5 Sirolimus 4 Therapeutics 3 Polymerase Chain Reaction 3 Cord Blood Stem Cell Transplantation 3 sargramostim 2 merphos 2 bempegaldesleukin 2 Vitamin B 12 2 Transplantation 2 Surgical Procedures, Operative 2 Prednisone 2 Oxaliplatin 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡